OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Hematology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	72
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	51
Hormetic endoplasmic reticulum stress in hematopoietic stem cells	47
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	26
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies	23
Deficits in our understanding of natural killer cell development in mouse and human	21
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	21
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	20
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy	18
Mesenchymal stromal cells: an update	17
Disparities in acute myeloid leukemia treatments and outcomes	17
Mechanisms of immunothrombosis in COVID-19	17
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	16
Developmental regulation of primitive erythropoiesis	16
Unraveling lipid metabolism for acute myeloid leukemia therapy	15
Platelet lifespan and mechanisms for clearance	15
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	15
The impact of obesity-induced inflammation on clonal hematopoiesis	14
Congenital neutropenia: disease models guiding new treatment strategies	14
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications	13
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells	12
High-throughput genotyping tools for red blood cell antigens	12
Humanized murine models of platelet function	11
Advances on the genetic basis of red cell membrane disorders	11
Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia	10

Multifaceted roles of CRISPR technology in blood cancer research	10
Editorial introductions	10
Editorial introduction	9
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	9
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	9
Editorial introductions	9
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	9
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies	8
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	8
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	8
Current Opinion in Hematology	7
Understanding and targeting erythroid progenitor cells for effective cancer therapy	7
Red blood cell changes due to cancer and cancer treatments: a narrative review	7
Editorial introductions	7
Editorial introductions	7
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	7
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	7
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	6
Translation defects in ribosomopathies	6
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	6
Modelling arterial thrombus formation in vitro	6
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	6
The immunology of PF4 polyanion interactions	6
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	5
Chediak-Higashi syndrome	5
Platelets and platelet–leukocyte interactions in infectious diseases	5
Platelet transfusion	5
Editorial introduction	5
The state of prediction models in hematologic disease: a worrisome assessment	5
Models to study myelodysplastic syndrome and acute myeloid leukaemia	5
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	5